menu toggle

Public Policy

Advocating for patient access to pharmaceutical care and a secure, efficient supply chain
US capitol color

Our extensive engagement with all segments of the healthcare spectrum – including primary and secondary care and pharmaceutical sites – and our federal and state legislative presence enables us to educate, influence and collaborate with policymakers on important pharmaceutical distribution and healthcare issues.

Championing healthier futures

Our dedicated Government Affairs & Policy team actively educates and engages policymakers at every level of government on human and animal health policy issues of importance to healthcare providers, patients and pharmaceutical supply chain stakeholders.
years combined team experience
In 2020 we conducted
virtual meetings with Federal & State legislators

Industry stewardship & policy priorities

By elevating and expanding our AmerisourceBergen associate grassroots advocate network with whom we partner and educate, we leverage our internal business expertise to advise and drive thought leadership throughout the industry.  Collectively we inform and engage policymakers on a nonpartisan basis to help shape legislation, regulations, laws and administration policies impacting patients, providers and the future of the most cost-effective pharmaceutical care.

Patient Access

We support regulatory and legislative policies that help ensure more people can access and afford needed treatments – including individuals negatively affected by the social determinants of health, such as race, education, ethnicity, social and economic status and those living in underserved urban and rural locations.  Our key-issue advocacy focus includes safe, efficient and reliable delivery of medicines, promoting the evolution of pharmaceutical benefit design and supporting the emerging biosimilars market.


In an ever-changing healthcare landscape, we support innovative solutions that yield improvements in treatments, drug delivery and ultimately patient care – including COVID-19 therapies, cell and gene therapies, vaccines, biosimilars and the Emergency Medicine Stockpile.  We inform federal and state elected officials about our secure, efficient and innovative pharmaceutical distribution network, which enables cost effectiveness across the entire pharmaceutical supply chain and ensures greater patient access to pharmaceuticals.

Community-Based Care

We support patient access to community-based care and believe in the empowering utility of delivering patient care in the most appropriate setting and at the right time – including through telehealth.  We continue to work on strengthening the vital role community practices, veterinarians, local health systems and independent and retail pharmacies play in ensuring patients receive quality and affordable care, where and when they need it.

Advocating for community-based pharmacies

Our Independent Voice

Through Our Independent Voice, we advocate on our customers' behalf to ensure issues important to independent and long-term care pharmacists are elevated. Areas of focus include provider status, access to patients, fair reimbursement, and FDA repackaging guidance.

Advocating for independent, community practices

Community Counts

Fair reimbursement, patient access, recognition for services provided—these are important issues for independent specialty providers. In supporting access to community-based care, we established Community Counts to ensure our collective voice is heard, understood, and acted upon.

Media Statement

AmerisourceBergen commends the introduction of S. 1909 & H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act, in Congress

Related Insights

Republican Democrat Healthcare


Let's Ditch 2020 and Plan for 2021: Election What-Ifs

October 2020



Biosimilars: Patents, policy, and reimbursement

Sean McGowan
October 2020

In the News

Media Statement

Media statement on Federal Retail Pharmacy Program

February 2, 2021

Press Release

AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine

November 2020

Media Mention

Advocating for Independent Community Pharmacies on Federal and State Levels

Drug Topics
September 17, 2020

Connect with us

Follow our Government Affairs and Policy team on social media